This guide provides step-by-step instructions for patients to self-administer BERINERT 500 IU for hereditary angioedema attacks after proper training from a…
The BERINERT Self-Administration Guide is a step-by-step slideshow designed to help patients who have received proper training from a healthcare professional to self-administer BERINERT for the treatment of acute hereditary angioedema (HAE) attacks. It includes important safety information, instructions for preparation and intravenous administration, and guidance on when to seek immediate medical attention, especially for laryngeal attacks.
The document also contains clinical study data demonstrating efficacy of BERINERT 20 IU/kg body weight dose, details on how the product is supplied (500 IU vial with administration kit), storage and handling requirements (2-30°C, do not freeze, protect from light), and patient counseling information regarding hypersensitivity reactions, thromboembolic events, and risks associated with human blood-derived products.
| Product Presentation | 500 IU vial for reconstitution with 10 mL Sterile Water for Injection, USP |
|---|---|
| Storage Temperature | 2-30°C (36-86°F) |
| Storage Precautions | Do not freeze, protect from light, keep in original carton until use |
Immediately seek medical attention in an appropriate healthcare facility after self-administering BERINERT for a laryngeal attack.
Clinical studies demonstrated that the BERINERT 20 IU/kg body weight dose was significantly more efficacious than the 10 IU/kg dose or placebo for treatment of acute abdominal or facial HAE attacks.